The 120 hospital-affiliated labs comprising the Michigan-based Joint Venture Hospital Laboratories (JVHL; Allen Park) are expanding their anatomic pathology (AP) and molecular diagnostic cancer testing offerings through a recently formed partnership with Clarient, a molecular diagnostic and AP specialty lab based in Aliso Viejo, California. Under the current one-year agreement, Clarient will do the technical work at its facility and send the results to JVHL pathologists through its Web-based application, PathSite. The pathologists will then perform the professional interpretation and manage those results with local clinicians.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

June 2008 - Table of Contents

LIR June 2008 (full PDF issue)

Prices Dropping on Some DTC Genetic Tests as SACGHS Urges Tighter Regs

G-2 Predicts Global Mol Dx Industry to Reach $5.5 Billion in 2008, $8 Billion by 2010

Quest, LabCorp Revenue/Requisition Metrics Strengthen in Q1

LabCorp’s Partners With Siemens, Acquires Louisiana Lab

Cost and Profit Analysis Is Key to Capturing Revenue Potential of Mol Dx Lab

Q1 08 Lab Benchmark Data Reveal Psychemedics Still a Leader, Enzo Posts Gains

JVHL Teams With Clarient to Expand Cancer AP Menu

Orchid Cellmark Wins $30 Million Forensic Testing Contract in U.K.

Lab Stocks Continue to Post Gains in May, up 8% Over 5 Weeks

Economic Development Incentives Fuel Genzyme Genetics’s Staff Expansion in Santa Fe